Sign in
CompletedNo phase

Effect of Warm Bupivacaine on Subtenon Block.

Key facts

Who runs it
Mansoura University
Where
Egypt1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
120 people enrolled
Started
1 Oct 2025
Ended
20 Jan 2026
Type of study
Interventional, 2 groups
Treatments tested
  • room temperature Bupivacaine
  • warm Bupivacaine
Record updated
27 January 2026

Who can take part

Age
18 years to 75 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 7 criteriaShow less

Who can take part

  • American Society of Anesthesiology (ASA) I, II or III patients
  • Patients scheduled for elective unilateral cataract surgery

Who cannot take part

  • Altered mental status or un-cooperative patients or psychiatric disorder
  • History of anesthetic drug allergy
  • Pre-existing progressive demyelinating neurologic pathology or neuromuscular disorders
  • Any contraindications to block (as bleeding or coagulation diathesis)
  • Patient refusal to participate in the study

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Sub-Tenon's anesthesia is now widely regarded as a preferred local anesthetic method for cataract surgery. Various techniques have been explored to prolong the duration, shorten onset time and improve the efficacy of local anesthetic nerve blocks with varying degrees of success. Warming local anesthetic may speed up its onset and prolong its effect by lowering its pKa.The aim of this study is to evaluate the effect of warming bupivacaine on the characteristics of a sub-Tenon's block in patients undergoing cataract surgery. It is hypothesized that warming bupivacaine 0.5% to 37°C will improve the characteristics of sub-Tenon's block. It will prolong the duration of sensory and motor block and accelerate the time onset time of sensory and motor block.

The 2 groups in the trial

  • Operating room temperature bupivacaineTreatment being tested

    patients will receive local anesthetic (5ml containing 5mg bupivacaine) that will be on a sterile shelf in the operating room at 23°C. The empty syringes and needles will be also on the same shelf before their use.

    Treatment: room temperature Bupivacaine

  • Warm bupivacaineTreatment being tested

    patients will receive local anesthetic (5ml containing 5mg bupivacaine) warmed to 37◦C for 20 minutes. The empty syringes and needles, in their packaging, will be held at the same temperature for at least 2 hours before initiating the block.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
The Influence Of Bupivacaine Temperature On Subtenon Block Characteristics: A Prospective, Randomized, Controlled Trial
Record updated
27 January 2026